582 related articles for article (PubMed ID: 15464946)
1. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy.
Nath R; Yue N
Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946
[TBL] [Abstract][Full Text] [Related]
2. Effects of vessel curvature on dose distributions in catheter-based intravascular brachytherapy for various radionuclides.
Yue N; Roberts K; Nath R
Cardiovasc Radiat Med; 2004; 5(3):142-50. PubMed ID: 15721850
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.
Yue N; Nath R; Roberts K
Cardiovasc Radiat Med; 2000; 2(1):32-8. PubMed ID: 11229060
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.
Yue N; Nath R; Roberts K
Cardiovasc Radiat Med; 2001 Jan; 2(1):32-38. PubMed ID: 11068253
[TBL] [Abstract][Full Text] [Related]
5. Dose distributions in bifurcated coronary vessels treated with catheter-based photon and beta emitters in intravascular brachytherapy.
Yue N; Roberts KB; Pfau SE; Nath R
Med Phys; 2003 Jul; 30(7):1628-36. PubMed ID: 12906180
[TBL] [Abstract][Full Text] [Related]
6. Recommendations on detectors and quality control procedures for brachytherapy beta sources.
Kollaard RP; Dries WJ; van Kleffens HJ; Aalbers TH; van der Marel H; Marijnissen HP; Piessens M; Schaart DR; de Vroome H
Radiother Oncol; 2006 Feb; 78(2):223-9. PubMed ID: 16457901
[TBL] [Abstract][Full Text] [Related]
7. A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations.
Parsai EI; Zhang Z; Feldmeier JJ
Brachytherapy; 2009; 8(3):318-23. PubMed ID: 19217355
[TBL] [Abstract][Full Text] [Related]
8. Toward endobronchial Ir-192 high-dose-rate brachytherapy therapeutic optimization.
Gay HA; Allison RR; Downie GH; Mota HC; Austerlitz C; Jenkins T; Sibata CH
Phys Med Biol; 2007 Jun; 52(11):2987-99. PubMed ID: 17505084
[TBL] [Abstract][Full Text] [Related]
9. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator.
Gifford KA; Mourtada F; Cho SH; Lawyer A; Horton JL
Radiother Oncol; 2005 Nov; 77(2):210-5. PubMed ID: 16216363
[TBL] [Abstract][Full Text] [Related]
11. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo dose calculations using MCNP4C and EGSnrc/BEAMnrc codes to study the energy dependence of the radiochromic film response to beta-emitting sources.
Pacilio M; Aragno D; Rauco R; D'Onofrio S; Pressello MC; Bianciardi L; Santini E
Phys Med Biol; 2007 Jul; 52(13):3931-48. PubMed ID: 17664586
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry calculation for a novel phosphorus-32-impregnated balloon angioplasty catheter for intravascular brachytherapy.
Yue N; Nath R; Hehrlein C
Cardiovasc Radiat Med; 1999; 1(4):349-57. PubMed ID: 10828565
[TBL] [Abstract][Full Text] [Related]
14. The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source.
Patel NS; Chiu-Tsao ST; Fan P; Tsao HS; Liprie SF; Harrison LB
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1093-102. PubMed ID: 11704334
[TBL] [Abstract][Full Text] [Related]
15. Shielding effects of metallic encapsulations and radiographic contrast agents for catheter-based intravascular brachytherapy.
Nath R; Yue N
Cardiovasc Radiat Med; 2001; 2(2):93-103. PubMed ID: 11340013
[TBL] [Abstract][Full Text] [Related]
16. (144)Ce as a potential candidate for interstitial and intravascular brachytherapy.
Zilio VO; Joneja OP; Popowski Y; Bochud FO; Chawla R
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):585-94. PubMed ID: 15890604
[TBL] [Abstract][Full Text] [Related]
17. Wire or coated balloon? Searching for an optimal source for intravascular brachytherapy with beta emitters using (32)P as an example.
Lehmann J; King CR
J Appl Clin Med Phys; 2003; 4(1):58-65. PubMed ID: 12540819
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric effect of source centering and residual plaque for beta-emitting catheter based intravascular brachytherapy sources.
Sehgal V; Li Z; Palta JR; Bolch WE
Med Phys; 2001 Oct; 28(10):2162-71. PubMed ID: 11695779
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
Poon E; Williamson JF; Vuong T; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
[TBL] [Abstract][Full Text] [Related]
20. The use of gel dosimetry to measure the 3D dose distribution of a 90Sr/90Y intravascular brachytherapy seed.
Massillon-Jl G; Minniti R; Mitch MG; Maryanski MJ; Soares CG
Phys Med Biol; 2009 Mar; 54(6):1661-72. PubMed ID: 19242054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]